PEAK6 Investments’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

PEAK6 Investments’s Portfolio HZNP Stock Details HZNP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-38,400	Closed	-$4.44M	–	5024
2023 Q3	$4.44M	Sell	38,400 -27,200	-41%	-$2.92M	0.02%	786
2023 Q2	$6.75M	Buy	+65,600	New	+$6.92M	0.03%	529
2023 Q1	–	Sell	-2,000	Closed	-$228K	–	5222
2022 Q4	$228K	Buy	+2,000	New	+$166K	﹤0.01%	3189
2022 Q3	–	Sell	-68,200	Closed	-$6.95M	–	6512
2022 Q2	$6.95M	Sell	68,200 -19,800	-23%	-$1.88M	0.01%	1122
2022 Q1	$9.26M	Buy	88,000 +56,900	+183%	+$5.55M	0.02%	729
2021 Q4	$3.35M	Buy	31,100 +20,600	+196%	+$2.25M	0.01%	1454
2021 Q3	$1.15M	Buy	+10,500	New	+$1.09M	﹤0.01%	2471
2019 Q1	–	Sell	-136,200	Closed	-$2.66M	–	4937
2018 Q4	$2.66M	Hold	136,200	–	–	0.02%	1032
2018 Q3	$2.67M	Buy	+136,200	New	+$2.59M	0.01%	1230

Other funds holding HZNP

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

BTI

Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

VWA

Valued Wealth Advisors Holladay, Utah $275M AUM 24.94% 1-Year Est. Return

FSWA

Financial Synergies Wealth Advisors Houston, Texas $1.18B AUM 31.41% 1-Year Est. Return

BCMLT

Beacon Capital Management LLC (Tennessee) Franklin, Tennessee $683M AUM 22.58% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

PEAK6 Investments's HZNP Position: Q2 2023 in Review

PEAK6 Investments sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q2 2023, closing a stake of 814 shares — an estimated $85.9K sold.

PEAK6 Investments first reported a position in HZNP in Q1 2021 and held it in 4 quarters. The position peaked at $839K in Q1 2021. 519 funds tracked by Wall St. Rank hold HZNP as of Q2 2023.

PEAK6 Investments reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q2 2023 after selling out during the quarter.
PEAK6 Investments sold 814 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q2 2023, an estimated $85.9K.
PEAK6 Investments first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q1 2021 and held it in 4 quarters.
PEAK6 Investments's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $839K in Q1 2021.
519 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q2 2023.

Based on PEAK6 Investments's 13F filing for Q2 2023, filed 11 Aug 2023.